Skip to main navigation
UroGen Pharma, Ltd logo
  • Who We Are
    • What We Stand For
    • Leadership
    • Advocacy/Unmet Need
    • Work With Us
    • Corporate Responsibility
  • Our Portfolio
    • RTGel® Technology
    • JELMYTO® (mitomycin) for pyelocalyceal solution
    • Partnerships
  • Pipeline
  • Media & Investors
    • Media
    • Investors
      • News Releases
      • Events
      • Financials
      • Governance
      • Stocks
      • Reports
      • Resources
  • Connect

We strive to put patients first and preserve their future possibilities

Investor Relations
  • Overview
  • News Releases
  • Events
  • Financials
  • Governance
  • Stock Info
  • Reports
  • Resources

Annual reports

2025 Annual Report
2025 Annual Report
download
2024 Annual Report
2024 Annual Report
download
2023 Annual Report
2023 Annual Report
download
2022 Annual Report
2022 Annual Report
download
2021 Annual Report
2021 Annual Report
download
2020 Annual Report
2020 Annual Report
download
2019 Annual Report
2019 Annual Report on Form 10-K
download
2018 Annual Report
2018 Annual Report on Form 10-K
download

Proxy statements

2026 - download
2025 - download
2024 - download
2023 - download
2022 - download
2021 - download
2020 - download
2019 - download
  • Print this Page
    Print Page
  • Link to Email Alerts page
    Email Alerts
  • Link to RSS page
    RSS Feeds
UroGen Pharma, Ltd logo
  • Who We Are
  • Our Portfolio
  • Pipeline
  • Media
  • Investors
  • Privacy Policy
  • Patent Notice
  • Terms of Use
  • Funding Requests
Follow Us: Linkedin opens in new window Twitter opens in new window
Connect

JELMYTO®, UroGen®, and RTGel® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

© 2026 UroGen Pharma, Ltd All rights reserved

US-UGN-00269 05/24